arrow Log In to View Account     |      
HOME
Johns Hopkins Medicine
Hopkins Logo


CENTRAL VEIN OCCLUSION WITH DIABETIC MACULAR EDEMA
 

Neil M. Bressler, MD

OVERVIEW

The retina community is experiencing an influx of information for the management and treatment of retinal vein occlusions (RVO) and diabetic macular edema (DME). This assortment of data mainly comes from clinical trials which are designed to test and assess various treatments, provide dosing recommendations, and combinations thereof for different patient populations. This activity will provide retina specialists with these emerging findings and offer opportunities to analyze and discuss this new information as it relates to daily clinical practice and clinical decision-making and the interactive case studies will focus on the practical application of new treatments for patients with RVO and DME.

GOAL

The goal of this educational activity is to help retina specialists meet individual patients’ needs based on each patient’s unique risk/benefit profile for optimal visual outcomes.

INTENDED AUDIENCE

This activity is designed for retina specialists and other ophthalmologists who manage patients with macular edema. No prerequisites required.

LEARNING OBJECTIVE

After participating in this activity, the participant should be able to:

  • EVALUATE the results of the latest clinical trials for the management of patients with RVO.
  • EVALUATE the results of the latest clinical trials for the management of patients with DME and other aspects of diabetic retinopathy.
  • APPLY results from the latest clinical trials in RVO and DME in clinical case scenarios.

The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.

ACCREDITATION STATEMENTS

The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENTS

The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The estimated time to complete this activity: 30 minutes.

Release date: November 15, 2010. Expiration date: November 15, 2012.

HOW TO RECEIVE CREDIT OR CONTACT HOURS

The following interactive case activity consists of 3 sections: a pre-test, an interactive case with decision points, and a CME post-test with an evaluation. All 3 sections must be completed to receive CME credit. A certificate of participation will be available online immediately following successful completion of the module.

FULL DISCLOSURE POLICY AFFECTING CME ACTIVITIES

As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of the Johns Hopkins University School of Medicine to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a provider has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The participating faculty reported the following:

Neil M. Bressler, MD (Chair)
The James P. Gills Professor of Ophthalmology
Chief, Retina Division
Wilmer Eye Institute
Johns Hopkins University School of Medicine
Baltimore, Maryland
Dr Bressler reports serving as principal investigator for Abbott Medical Optics, Allergan, Inc, Bausch & Lomb Incorporated, Carl Zeiss Meditec, Inc,The EMMES Corporation, ForSight Labs, LLC, Genentech, Inc, Genzyme Corporation, Lumenis, Notal Vision, Novartis Pharmaceuticals Corporation, QLT Inc, Regeneron Pharmaceuticals, Inc, and Steba Biotech. Dr Bressler also reports his that his spouse, Susan Bressler, MD, is a consultant for GlaxoSmithKline, Notal Vision, and Sightpath Medical.

Note: Grants to investigators at the Johns Hopkins University are negotiated and administered by the institution that receives the grant, typically through the Office of Research Administration. Individual investigators who participate in the sponsored project(s) are not directly compensated by the sponsor, but may receive salary or other support from the institution to support their effort on the project(s).

OFF-LABEL PRODUCT DISCUSSION

The following faculty members have disclosed that their presentation will reference unlabeled/unapproved use of drugs or products:

Dr Neil M. Bressler—bevacizumab, ranibizumab, and triamcinolone acetonide.

DISCLAIMER

The opinions and recommendations expressed by faculty and other experts whose input is included in this activity are their own. This activity is produced for educational purposes only. Use of the Johns Hopkins University School of Medicine name implies review of educational format, design, and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings, and adverse effects before administering pharmacologic therapy to patients.

INTERNET CME POLICY

The Office of Continuing Medical Education (CME) at the Johns Hopkins University School of Medicine is committed to protect the privacy of its members and customers. Johns Hopkins University SOM CME maintains its Internet site as an information resource and service for physicians, other health professionals, and the public. Continuing Medical Education at the Johns Hopkins University School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet based activity. Your information will never be given to anyone outside of the Johns Hopkins University School of Medicine’s CME activity. CME collects only the information necessary to provide you with the services that you request.

ACTIVITY
Instructions
The following is an interactive educational case module designed to help you gauge your basic knowledge of the topic and then direct you to areas you may need to focus on. It consists of 3 sections: an unaccredited pre-test, an interactive case study, and a CME post-test. All 3 sections must be completed to receive CME credit.

Pre-Test

Central Vein Occlusion with Diabetic Macular Edema
Neil M. Bressler, MD

Post-Test

Supported by an educational grant from Genentech, Inc.

procced to pretest
footer